Myasthenia Gravis News

January 13, 2022January 13, 2022

PRO Tool May Better Address MG Symptoms Most Affecting Patients

By analyzing available research and conducting nearly 100 interviews with patients, an international team of researchers crafted a new tool to measure the severity of myasthenia gravis (MG) based on ... Read more

January 11, 2022January 11, 2022

Argenx Gears Up for US Launch of Vyvgart, Awaiting EU Decision

Myasthenia Gravis News

Argenx is working toward the commercial launch of Vyvgart (efgartigimod) — recently approved by the U.S. Food and Drug Administration (FDA) — to treat adults in the U.S. with generalized ... Read more

January 6, 2022January 6, 2022

Immunovant to Launch US Phase 3 Trial for Batoclimab in MG

Myasthenia Gravis News

Immunovant is moving forward with its Phase 3 clinical trial in the U.S. to evaluate the investigational myasthenia gravis (MG) therapy batoclimab in the first half of this year. The ... Read more

January 4, 2022January 4, 2022

Case Report Highlights Rare Form of MG Affecting Newborns

Myasthenia Gravis News

Infants born to women with myasthenia gravis (MG) may develop a rare condition called transient neonatal myasthenia gravis (TNMG), which needs to be properly recognized in order to be appropriately ... Read more

December 28, 2021December 28, 2021

Merck Acquiring Cladribine as Potential Generalized MG Treatment

Myasthenia Gravis News

Merck KGaA has acquired Chord Therapeutics and the rights to continue developing CRD1 (cladribine), Chord’s lead candidate for treatment of generalized myasthenia gravis. “I am particularly pleased that Chord’s focus ... Read more

December 23, 2021December 23, 2021

Ultomiris Under Priority FDA Review as Potential gMG Treatment

COVID-19 News, Myasthenia Gravis News

The U.S. Food and Drug Administration (FDA) has accepted and placed on priority review an application seeking the approval of Ultomiris (ravulizumab-cwvz) to treat adults with generalized myasthenia gravis (gMG). ... Read more

December 21, 2021December 21, 2021

Ultomiris Rapidly Eases Symptoms of Generalized MG in Phase 3 Trial

COVID-19 News, Myasthenia Gravis News

Treatment with Ultomiris (ravulizumab-cwvz), a complement-blocking therapy, quickly eased symptom severity in adults with generalized myasthenia gravis (gMG), according to data from a Phase 3 trial. Findings were shared at ... Read more

December 20, 2021December 20, 2021

FDA Approves Vyvgart for Adults With Most Common Form of gMG

Myasthenia Gravis News

Vyvgart (efgartigimod) has been approved by the U.S. Food and Drug Administration (FDA) to treat adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive, the therapy’s developer, Argenx, ... Read more

December 16, 2021December 16, 2021

MG Onset Follows Surgery to Remove Thymus in Case Study

Myasthenia Gravis News

In an older woman, myasthenia gravis (MG) onset followed surgery to remove a thymoma, or tumor of the thymus, a case study reported. Doctors should actively check for MG symptoms in ... Read more

December 14, 2021December 14, 2021

Rozanolixizumab May Safely Ease Symptom Severity in gMG Patients

Myasthenia Gravis News

Rozanolixizumab, UCB’s investigational antibody, may ease symptom severity in adults with generalized myasthenia gravis (MG), and help them carry on with daily activities, top-line data from the Phase 3 MycarinG ... Read more

December 9, 2021December 9, 2021

Analyzing Certain Immune Cells in Thymomas May Help to Predict MG

Myasthenia Gravis News

Determining whether two types of immune cells — T follicular helper cells and activated dendritic cells — are present or lacking in a thymoma, in addition to the levels of specific ... Read more

December 7, 2021December 7, 2021

MuSK-MG Linked to Eye and Bulbar Symptoms, Chinese Study Finds

Myasthenia Gravis News

A type of myasthenia gravis (MG) caused by the presence of self-reactive antibodies targeting muscle-specific kinase (MuSK) affects mostly women and manifests with eye and bulbar symptoms (those involving the ... Read more

December 2, 2021December 2, 2021

Gender, Race, and Thymectomy Increase Risk for Lupus in MG

Myasthenia Gravis News

People with myasthenia gravis (MG) have an increased risk of developing systemic lupus erythematosus or SLE, another type of autoimmune disorder, according to recent study findings that suggest “a real ... Read more

November 30, 2021November 30, 2021

Rare Case Report Attributes MG in Elderly Man to COVID-19 Vaccine

COVID-19 News, Myasthenia Gravis News

An 82-year-old man was diagnosed with myasthenia gravis (MG) shortly after receiving his second dose of the BioNTech/Pfizer COVID-19 vaccine, a case study reports. He lacked typical MG symptoms, but ... Read more